Proactive Investors - Run By Investors For Investors
Why invest in BIO?
Biome Grow Inc.: DEEP DIVE
OVERVIEW

Biome Grow subsidiary inks 24,000kg supply deal with Province of Newfoundland and Labrador

Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
Biome Grow subsidiary inks 24,000kg supply deal with Province of Newfoundland and Labrador
OVERVIEW: BIO The Big Picture
The company will also invest $500,000 over five years for research and development in the Province

Biome Grow Inc (CSE:BIO) told investors Friday it had struck the largest cannabis supply agreement to date in Atlantic Canada.

Subsidiary Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement with the Province of Newfoundland and Labrador, it said, marking one of the top five largest deals of its kind in the Canadian cannabis market by quantity.

Significantly, Biome expects that the supply deal will represent close to $100 million in revenue a year from the beginning of 2020.

Research and development

The company will also invest $500,000 over five years for research and development in the Province.

"Today's announcement is part of Biome's strategic plan to invest in sustainable production facilities and ecosystems across Atlantic Canada," said Khurram Malik, CEO of Biome.

"The region provides Biome with the benefit of having a local customer base and governments that value the company's invest local, hire local, and brand local' approach to building sustainable cannabis ecosystems.

"Furthermore, this supply agreement allows Back Home to make the investment to create a large employment base that will create high-quality products for both the local market and for customers in international jurisdictions that are looking for a Made in Canada' offering."

Back Home's new $60 million production facility will operate from Barachois Brook on the west coast of Newfoundland.

Multiple phases

It will be built in multiple phases with an initial 18,000 square feet (sq ft) expanded to a further 150,000 sq ft in 2019.

The expansion will bring the company's total footprint to 168,000 sq ft, making it the largest cannabis production facility in Newfoundland and Labrador.

Biome will receive access to five retail licenses and the deal means the creation of a minimum of 120 jobs at Back Home's production facility, with  around an additional 80 jobs for Back

Home's five retail stores and associated infrastructure in Newfoundland and Labrador.

Back Home expects to produce Newfoundland and Labrador-grown cannabis in 2019 and plans to operate its production facility in the province for at least 20 years.

Committed to supply

Biome has committed to supplying up to 4,000 kgs in the first year of its three-year contract, with 10,000 kgs annually in the following two years from across its portfolio of production assets.

Rapidly growing pot firm Biome has acquired five subsidiaries and has so far announced around 390,000 sq ft of production capacity in operation or under development in Ontario and Atlantic Canada.

Shares in Toronto stand at $1.05 each.

Reporting by Giles Gwinnett

[email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full BIO profile View Profile

Biome Grow Inc. Timeline

Related Articles

cannabis plant
May 05 2019
The cannabis company invests in income-producing property and provides financing solutions and capital investment to service the blossoming cannabis industry
1541165310_canadian-flag-1.jpg
November 02 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
cannabis
June 08 2019
1933 Industries is progressing with plans to launch one of Nevada's largest hemp extraction facilities, amid a flurry of other activity
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use